Q4 2025 Holdings
Filed 2026-02-17 | 77 holdings | $430.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.0M | 159,736 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.0M | 304,775 | 0.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.3M | 130,175 | 1.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $4.4M | 261,583 | 1.0% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $5.2M | 165,265 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $5.3M | 318,500 | 1.2% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $5.5M | $4,000,000 | 1.3% |
| Inogen Inc(INGN) | COM | 45780L104 | $5.6M | 827,071 | 1.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.6M | 811,046 | 1.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.8M | 356,802 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.8M | 277,855 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.9M | 88,279 | 1.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.0M | 28,177 | 1.4% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $7.8M | 355,208 | 1.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.3M | 999,163 | 2.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $10.0M | 70,615 | 2.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $10.3M | 431,329 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $10.8M | 955,235 | 2.5% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $11.5M | 68,095 | 2.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.9M | 287,939 | 3.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $15.6M | 476,826 | 3.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $17.5M | 506,740 | 4.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $23.6M | 370,997 | 5.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $23.6M | 597,431 | 5.5% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $31.5M | 13,680,554 | 7.3% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $41.0M | 336,505 | 9.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $48.1M | 604,514 | 11.2% |